Also known as: Plant Sterol, Phytosterol, Beta-Sitosterin
Beta-sitosterol is a plant sterol structurally similar to cholesterol that competitively inhibits intestinal cholesterol absorption. It has strong evidence for lowering LDL cholesterol and emerging research for benign prostatic hyperplasia (BPH) symptom relief.
Beta-sitosterol is the most abundant phytosterol found in plant-based foods, including vegetable oils, nuts, seeds, and legumes. Its molecular structure closely resembles cholesterol, allowing it to compete with dietary and biliary cholesterol for absorption in the intestinal lumen via the Niemann-Pick C1-Like 1 (NPC1L1) transporter. This mechanism reliably reduces LDL cholesterol by 5–15% when consumed at doses of 2–3 g per day, and has been endorsed by the FDA, EFSA, and multiple cardiovascular guidelines as an adjunctive dietary strategy. Beyond lipid management, beta-sitosterol has demonstrated efficacy in several randomized controlled trials for improving urinary symptoms associated with benign prostatic hyperplasia, likely through anti-inflammatory effects and inhibition of 5-alpha-reductase activity. It is generally well tolerated, though rare cases of sitosterolemia (a genetic condition causing excessive phytosterol absorption) represent a contraindication.
A meta-analysis of 84 trials confirmed that plant sterol intake of 2–3 g/day reduces LDL cholesterol by an average of 9–12%. Beta-sitosterol competes with cholesterol for intestinal absorption, reducing circulating LDL without affecting HDL.
A Cochrane review of four RCTs found that beta-sitosterol significantly improved urinary symptom scores and flow measures in men with benign prostatic hyperplasia compared to placebo.
Divided across meals; must be taken with fat-containing food for absorption
FDA-authorized health claim supports 2 g/day of plant sterols. Effects plateau above 3 g/day with no additional LDL reduction. Consistent daily use for 2–3 weeks required to see full effect.
Divided into 2–3 doses daily
Clinical trials used isolated beta-sitosterol at lower doses than those used for cholesterol management. Improvements in symptom scores may take 4–6 weeks.
Targeted prostate health support
Cholesterol management as part of daily diet
No reviews yet. Be the first to share your experience!
No product recommendations yet.